Success Metrics

Clinical Success Rate
85.2%

Based on 75 completed trials

Completion Rate
85%(75/88)
Active Trials
52(28%)
Results Posted
29%(22 trials)
Terminated
13(7%)

Phase Distribution

Ph phase_1
9
5%
Ph early_phase_1
6
3%
Ph phase_3
4
2%
Ph not_applicable
67
36%
Ph phase_4
3
2%
Ph phase_2
12
6%

Phase Distribution

15

Early Stage

12

Mid Stage

7

Late Stage

Phase Distribution101 total trials
Early Phase 1First-in-human
6(5.9%)
Phase 1Safety & dosage
9(8.9%)
Phase 2Efficacy & side effects
12(11.9%)
Phase 3Large-scale testing
4(4.0%)
Phase 4Post-market surveillance
3(3.0%)
N/ANon-phased studies
67(66.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.1%

75 of 96 finished

Non-Completion Rate

21.9%

21 ended early

Currently Active

52

trials recruiting

Total Trials

186

all time

Status Distribution
Active(59)
Completed(75)
Terminated(21)
Other(31)

Detailed Status

Completed75
Recruiting42
unknown29
Terminated13
Active, not recruiting10
Withdrawn8

Development Timeline

Analytics

Development Status

Total Trials
186
Active
52
Success Rate
85.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (5.9%)
Phase 19 (8.9%)
Phase 212 (11.9%)
Phase 34 (4.0%)
Phase 43 (3.0%)
N/A67 (66.3%)

Trials by Status

active_not_recruiting105%
suspended21%
not_yet_recruiting42%
terminated137%
withdrawn84%
unknown2916%
completed7540%
enrolling_by_invitation32%
recruiting4223%

Recent Activity

Clinical Trials (186)

Showing 20 of 186 trialsScroll for more
NCT07226453Phase 2

Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

Recruiting
NCT02826733

Evaluation of the Implementation of the Hemispheric Dominance During Development

Completed
NCT07498270Not Applicable

Location- and Frequency-Dependent Effects of Thalamic Temporal Interference Stimulation During Sleep

Recruiting
NCT07110246Phase 2

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

Recruiting
NCT04426188Not Applicable

" Acute Brain Changes After Repetitive Headers in Soccer and the Effects of a Protective Device "

Completed
NCT05599048Phase 1

Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

Recruiting
NCT06355778Not Applicable

Adversity, Brain and Opioid Use Study

Recruiting
NCT04346225Phase 2

Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer

Recruiting
NCT06557512Not Applicable

Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma

Recruiting
NCT07346170Not Applicable

Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases

Not Yet Recruiting
NCT02829190Phase 3

Feasibility Study of Phase-contrast MRI for Flow in the External Carotid Branches Arteries

Recruiting
NCT05486520Not Applicable

Low-field MRI for Breast Cancer Screening

Enrolling By Invitation
NCT07275723Phase 3

A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions

Active Not Recruiting
NCT05427136

Early Pulmonary Dysfunction in Childhood Cancer Patients

Recruiting
NCT07044596Not Applicable

Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline

Recruiting
NCT06960343

Long Term Clinical Outcome After Arthroscopic Rotator Cuff Repair Augmentation With Autologous Microfragmented Lipoaspirate Tissue

Recruiting
NCT05710380Not Applicable

MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

Recruiting
NCT03729115Not Applicable

A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer

Recruiting
NCT05887882Phase 1

Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors

Suspended
NCT04424030

International Consortium for Multimodality Phenotyping in Adults With Non-compaction

Active Not Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
186